These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26439044)

  • 21. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.
    Fan Z; Liang Z; Yang H; Pan Y; Zheng Y; Wang X
    J Neuroinflammation; 2017 Dec; 14(1):256. PubMed ID: 29262843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease.
    Wang XH; Xie X; Luo XG; Shang H; He ZY
    Mol Med Rep; 2017 Feb; 15(2):768-776. PubMed ID: 28035410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model.
    Lazzarini M; Martin S; Mitkovski M; Vozari RR; Stühmer W; Bel ED
    Glia; 2013 Jul; 61(7):1084-100. PubMed ID: 23595698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide.
    Liu B; Jiang JW; Wilson BC; Du L; Yang SN; Wang JY; Wu GC; Cao XD; Hong JS
    J Pharmacol Exp Ther; 2000 Oct; 295(1):125-32. PubMed ID: 10991969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
    Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
    Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway.
    Wu SY; Wang TF; Yu L; Jen CJ; Chuang JI; Wu FS; Wu CW; Kuo YM
    Brain Behav Immun; 2011 Jan; 25(1):135-46. PubMed ID: 20851176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Endophilin A1 in Lipopolysaccharide-Induced Parkinson's Disease Model Mice.
    Han J; Liu M; Ling Y; Ren Y; Qiu Y; Liu Y; Yin Y
    J Parkinsons Dis; 2023; 13(5):743-756. PubMed ID: 37334616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glial Reaction in a Neuroinflammatory Model of Parkinson's Disease.
    Voronkov DN; Stavrovskaya AV; Potapov IA; Guschina AS; Olshanskiy AS
    Bull Exp Biol Med; 2023 Mar; 174(5):693-698. PubMed ID: 37043065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meloxicam reduces lipopolysaccharide-induced degeneration of dopaminergic neurons in the rat substantia nigra pars compacta.
    Sui Y; Stanić D; Tomas D; Jarrott B; Horne MK
    Neurosci Lett; 2009 Aug; 460(2):121-5. PubMed ID: 19450656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
    Sharma N; Nehru B
    Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plantamajoside Alleviates Substantia Nigra Damage in Parkinson's Disease Mice by Inhibiting HDAC2/MAPK Signaling and Reducing Microglia Polarization.
    Guo X; Chen L; Li J
    ACS Chem Neurosci; 2023 Mar; 14(6):1119-1125. PubMed ID: 36859770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease.
    Li H; He Z; Su T; Ma Y; Lu S; Dai C; Sun M
    Neurol Res; 2003 Apr; 25(3):263-7. PubMed ID: 12739234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits.
    Zhang J; Stanton DM; Nguyen XV; Liu M; Zhang Z; Gash D; Bing G
    Neuroscience; 2005; 135(3):829-38. PubMed ID: 16165292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lesion-associated microglia and macrophages mediate corralling and react with massive phagocytosis for debris clearance and wound healing after LPS-induced dopaminergic depletion.
    Heman-Bozadas P; Romero C; Martínez-Remedios P; Freitag I; Frías A; Saavedra-López E; Casanova PV; Roig-Martínez M; Cribaro GP; Rovirosa-Hernández MJ; Hernandez-Baltazar D; Barcia C
    J Neuroimmunol; 2022 Jun; 367():577874. PubMed ID: 35490443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice.
    Wang QM; Xu YY; Liu S; Ma ZG
    Oncotarget; 2017 Jul; 8(29):47284-47295. PubMed ID: 28521299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanism of α-lipoic acid promoting iron efflux in substantia nigra cells of Parkinson's disease rats].
    Cai T; Wei C; Zhai S; Tai S; Zhang C; Jiao L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jan; 34(1):35-40. PubMed ID: 29595455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A partial lesion of the substantia nigra pars compacta and retrorubral field decreases the harmaline-induced glutamate release in the rat cerebellum.
    Gołembiowska K; Berghauzen-Maciejewska K; Górska A; Kamińska K; Ossowska K
    Brain Res; 2013 Nov; 1537():303-11. PubMed ID: 24012623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
    Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
    Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system.
    Herrera AJ; Castaño A; Venero JL; Cano J; Machado A
    Neurobiol Dis; 2000 Aug; 7(4):429-47. PubMed ID: 10964613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.